Patient blood management (part 2) practice: The 3 pillars;Patient Blood Management (Teil 2) Praktisches Vorgehen: Die 3 Säulen

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 46, Issue 7-8, 2011, Pages 466-474

  Gombotz, Hans ^a   Hofman, Axel ^a   Rehak, Peter ^a   Kurz, Johann ^a  

^a NONE

Author keywords

anemia; blood loss; erythropoetin; iron; patient blood management; transfusion

Indexed keywords

ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEMATOCRIT; HUMAN; PATIENT BLOOD MANAGEMENT; PATIENT CARE; PATIENT IDENTIFICATION; PHYSIOLOGY; PRESSURE; RISK REDUCTION; SURGICAL PATIENT;

ANEMIA; AUSTRIA; BENCHMARKING; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; ERYTHROPOIETIN; HEMATOLOGIC DISEASES; HUMANS; INTRAOPERATIVE CARE; OPERATIVE BLOOD SALVAGE; PATIENT CARE MANAGEMENT; PERIOPERATIVE CARE; PLASMA SUBSTITUTES; PLATELET TRANSFUSION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE;

EID: 80051771118     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-0031-1284465     Document Type: Article

References (136)

1. Gombotz H, Hofmann A, Rehak P, Kurz J. Patient Blood Management (Teil 1) Individuelles Behandlungskonzept zur Reduktion und Vermeidung von Anmie, Blutverlust und -transfusionen. Ansthesiol, Intensivmed, Notfallmed, Schmerzther: 2011; 46 396 401
2. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery the Austrian benchmark study. Transfusion: 2007; 47 1468 1480 (Pubitemid 47101072)
3. Bennett-Guerrero E, Zhao Y, O'Brien SM et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA: 2010; 304 1568 1575
4. Moskowitz DM, McCullough JN, Shander A et al. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? Ann Thorac Surg: 2010
5. Shander A, Hofmann A, Ozawa S et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion: 2010; 50 753 765
6. Ferraris VA, Brown JR, Despotis GJ et al. 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg: 2011; 91 944 982
7. Beris P, Munoz M, Garcia-Erce JA et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth: 2008; 100 100
8. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol: 2006; 01
9. Theusinger OM, Leyvraz PF, Schanz U et al. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology: 2007; 107 923 927 (Pubitemid 350175674)
10. Zauber NP, Zauber AG, Gordon FJ et al. Iron supplementation after femoral head replacement for patients with normal iron stores. JAMA: 1992; 267 525 527
11. Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr: 1970; 100 301 303
12. Goodnough LT, Verbrugge D, Marcus RE, Goldberg V. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation. J Am Coll Surg: 1994; 179 171 176 (Pubitemid 24243750)
13. Mercuriali F, Intaglietta M. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin: 1996; 13 465 478 (Pubitemid 26402690)
14. Mercuriali F, Inghilleri G, Biffi E et al. Comparison between intravenous and subcutaneous recombinant human erythropoietin (Epoetin alfa) administration in presurgical autologous blood donation in anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Vox Sang: 1997; 72 93 100 (Pubitemid 27107446)
15. Bokemeyer C, Aapro MS, Courdi A et al. EORTC guidelines for the use of erythro-poietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer: 2007; 43 258 270 (Pubitemid 46127840)
16. Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion: 2008; 48 988 1000 (Pubitemid 351614910)
17. Weltert L, D'Alessandro S, Nardella S et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg: 2009; 139 621 627
18. Na HS, Shin SY, Hwang JY et al. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion: 2011; 51 118 124
19. Goodnough LT, Rudnick S, Price TH et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med: 1989; 321 1163 1168 (Pubitemid 19255812)
20. Kulier AH, Gombotz H, Fuchs G et al. Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery. Anesth Analg: 1993; 76 102 106 (Pubitemid 23094820)
21. Chun TY, Martin S, Lepor H. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology: 1997; 50 727 732 (Pubitemid 27494994)
22. Gombotz H, Gries M, Sipurzynski S et al. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. Acta Anaesthesiol Scand: 2000; 44 737 742 (Pubitemid 30413418)
23. Qvist N, Boesby S, Wolff B, Hansen CP. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery prospective double-blind placebo-controlled study. World J Surg: 1999; 23 30 35 (Pubitemid 28565556)
24. Feagan BG, Wong CJ, Kirkley A et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med: 2000; 133 845 854
25. Addeo R, Caraglia M, Frega N et al. Two faces for Janus: recombinant human erythropoiesis-stimulating agents and cancer mortality. Expert Rev Hematol: 2009; 2 513 515
26. Brookhart MA, Schneeweiss S, Avorn J et al. Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA: 2010; 303 857 864
27. Lorentz A, Jendrissek A, Eckardt KU et al. Serial immunoreactive erythropoietin levels in autologous blood donors. Transfusion: 1991; 31 650 654
28. Lee GC, Cushner FD. The effects of preoperative autologous donations on perioperative blood levels. J Knee Surg: 2007; 20 205 209
29. Tinmouth A, Fergusson D, Yee IC, Hebert PC. Clinical consequences of red cell storage in the critically ill. Transfusion: 2006; 46 2014 2027 (Pubitemid 44631611)
30. Gauvin F, Spinella PC, Lacroix J et al. Association between length of storage of transfused red blood cells and multiple organ dysfunction syndrome in pediatric intensive care patients. Transfusion: 2010; 50 1902 1913
31. van de Watering L. Red cell storage and prognosis. Vox Sang: 2011; 100 36 45
32. Sowade O, Warnke H, Scigalla P et al. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood: 1997; 89 411 418 (Pubitemid 27051675)
33. Forgie MA et al. for the International Study of Perioperative Transfusion Investigators. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. Arch Intern Med: 1998; 158 610 616 (Pubitemid 28144818)
34. de Benoist B, McLean E, Egli I, Cogswell M. (ed.) Worldwide prevalence of anaemia 19932005: WHO global database on anaemia. WHO Library Cataloguing-in-Publication Data: 2008
35. Guralnik JM, Eisenstaedt RS, Ferrucci L et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood: 2004; 104 2263 2268 (Pubitemid 39331821)
36. Ania BJ, Suman VJ, Fairbanks VF, Melton LJ. Prevalence of anemia in medical practice: community versus referral patients. Mayo Clin Proc: 1994; 69 730 735 (Pubitemid 24238071)
37. Endres HG, Wedding U, Pittrow D et al. Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women. Current Medical Research and Opinion: 2009; 25 1143 1158
38. Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 Guidelines on peri-operative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation: 2007; 116
39. Goodnough LT, Shander A, Spivak JL et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg: 2005; 101 1858 1861 (Pubitemid 41720652)
40. Goodnough LT, Maniatis A, Earnshaw P et al. Detection, evaluation, and manage-ment of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth: 2011; 106 13 22
41. Shander A, Spence RK, Auerbach M. Can intravenous iron therapy meet the unmet needs created by the new restrictions on erythropoietic stimulating agents? Transfusion: 2010; 50 719 732
42. Bolger AP, Bartlett FR, Penston HS et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol: 2006; 48 1225 1227 (Pubitemid 44345150)
43. Toblli JE, Lombrana A, Duarte P, Di GF. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol: 2007; 50 1657 1665 (Pubitemid 47562670)
44. Anker SD, Comin CJ, Filippatos G et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med: 2009; 361 2436 2448
45. Kell D. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Medical Genomics 10.1186/1755-8794-2-2: 2009; 2
46. Weinberg ED. Iron depletion: a defense against intracellular infection and neoplasia. Life Sci: 1992; 50 1289 1297
47. Daoud E, Nakhla E, Sharma R. Q: Is iron therapy for anemia harmful in the setting of infection? Cleveland Clinic Journal of Medicine: 2011; 78 168 170
48. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer: 2001; 91 2214 2221 (Pubitemid 32552805)
49. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med: 2005; 352 1011 1023
50. Henry DH. Parenteral iron therapy in cancer-associated anemia. Hematology: 2010; 2010 351 356
51. Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth: 2005; 95 130 139 (Pubitemid 41487135)
52. Hess JR, Brohi K, Dutton RP et al. The coagulopathy of trauma: a review of mechanisms. J Trauma: 2008; 65 748 754
53. Niles SE, McLaughlin DF, Perkins JG et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma: 2008; 64 1459 1463
54. Filicori F, Di Saverio S, Casali M et al. Packing for damage control of nontraumatic intra-abdominal massive hemorrhages. World J Surg: 2010; 34 2064 2068
55. Zwart JJ, Dijk PD, van Roosmalen J. Peripartum hysterectomy and arterial embo-lization for major obstetric hemorrhage: a 2-year nationwide cohort study in the Netherlands. Am J Obstet Gynecol: 2010; 202 150 157
56. Blackwell KE, Ross DA, Kapur P, Calcaterra TC. Propofol for maintenance of general anesthesia: a technique to limit blood loss during endoscopic sinus surgery. Am J Otolaryngol: 1993; 14 262 266 (Pubitemid 23215083)
57. Mauermann WJ, Shilling AM, Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg: 2006; 103 1018 1025 (Pubitemid 44576715)
58. Hu S, Zhang ZY, Hua YQ et al. A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis. J Bone Joint Surg Br: 2009; 91 935 942
59. Choi WS, Samman N. Risks and benefits of deliberate hypotension in anaesthesia a systematic review. Int J Oral Maxillofac Surg: 2008; 37 687 703
60. Habler O. Controlled hypotension. Anaesthesist: 2000; 49 687 689 (Pubitemid 30639775)
61. Pierce V, Kendrick P. Ischemic optic neuropathy after spine surgery. AANA J: 2010; 78 141 145
62. Farnham SB, Webster TM, Herrell SD, Smith JA Jr. Intraoperative blood loss and transfusion requirements for robotic-assisted radical prostatectomy versus radical retropubic prostatectomy. Urology: 2006; 67 360 363 (Pubitemid 43189856)
63. Chin JL, Srigley J, Mayhew LA et al. Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base. Can Urol Assoc J: 2010; 4 13 25
64. Maisano F, Kjaergard HK, Bauernschmitt R et al. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur J Cardiothorac Surg: 2009; 36 708 714
65. Fawzy H, Elmistekawy E, Bonneau D et al. Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. J Cardiothorac Surg: 2009; 4 25 25
66. Moumoulidis I, Martinez Del Pero M, Brennan L, Jani P. Haemostasis in head and neck surgical procedures: Valsalva manoeuvre versus Trendelenburg tilt. Ann R Coll Surg Engl: 2010; 92 292 294
67. Frilling A, Stavrou GA, Mischinger HJ et al. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection a randomised prospective trial. Langenbecks Arch Surg: 2005; 390 114 120 (Pubitemid 40487434)
68. Herrera S, Bordas JM, Llach J et al. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc: 2008; 68 440 446
69. Helal AS, Abdel-Hady E, Refaie E et al. Preliminary uterine artery ligation versus pericervical mechanical tourniquet in reducing hemorrhage during abdominal myomectomy. Int J Gynaecol Obstet: 2010; 108 233 235
70. Casati V, Benussi S, Sandrelli L et al. Intraoperative moderate acute normovolemic hemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery. Anesth Analg: 2004; 98
71. Terai A, Terada N, Yoshimura K et al. Use of acute normovolemic hemodilution in patients undergoing radical prostatectomy. Urology: 2005; 65 1152 1156 (Pubitemid 40824908)
72. Bennett J, Haynes S, Torella F et al. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion: 2006; 46 1097 1103 (Pubitemid 44139482)
73. Jones SB, Whitten CW, Despotis GJ, Monk TG. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg: 2003; 96
74. Singbartl K, Innerhofer P, Radvan J et al. Hemostasis and hemodilution a quantitative mathematical guide for clinical practice. Anesth Analg: 2003
75. Huet C, Salmi LR, Fergusson D et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg: 1999; 89 861 869 (Pubitemid 29458457)
76. Carless PA, Henry DA, Moxey AJ et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev CD 001888: 2010; 3
77. Steffens TG, Kohmoto T, Edwards N et al. Effects of modified ultrafiltration on coagulation as measured by the thromboelastograph. J Extra Corpor Technol
78. Oswald E, Streif W, Hermann M et al. Intraoperatively salvaged red blood cells contain nearly no functionally active platelets, but exhibit formation of micro-particles: results of a pilot study in orthopedic patients. Transfusion: 2010; 50 50
79. Hansen E, Bechmann V, Altmeppen J. Intraoperative blood salvage in cancer surgery: safe and effective? Transfus Apher Sci: 2002; 27 153 157 (Pubitemid 34876948)
80. Waters JH, Tuohy MJ, Hobson DF, Procop G. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology: 2003; 99 652 655 (Pubitemid 37051981)
81. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth: 2010; 105 401 416
82. Liumbruno GM, Liumbruno C, Rafanelli D. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion 10.1111/j.1537-2995. 2011.03116.x: 2011
83. Murray DJ, Pennell BJ, Weinstein SL, Olson JD. Packed red cells in acute blood loss: dilutional coagulopathy as a cause of surgical bleeding. Anesth Analg: 1995; 80 336 342
84. Valeri CR, Cassidy G, Pivacek LE et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion: 2001; 41 977 983 (Pubitemid 33642786)
85. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion: 2005; 45 1413 1425 (Pubitemid 44194644)
86. Chee YL, Crawford JC, Watson HG, Greaves M. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol: 2008; 140 496 504 (Pubitemid 351230081)
87. Enriquez LJ, Shore-Lesserson L. Point-of-care coagulation testing and transfusion algorithms. Br J Anaesth: 2009; 103 01
88. Ak K, Isbir CS, Tetik S et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg: 2009; 24 404 410
89. Sperry JL, Ochoa JB, Gunn SR et al. An FFP:PRBC transfusion ratio 1:1,5 is associated with a lower risk of mortality after massive transfusion. J Trauma
90. Zink KA, Sambasivan CN, Holcomb JB et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg: 2009; 197 565 570
91. Duchesne JC, Islam TM, Stuke L et al. Hemostatic resuscitation during surgery improves survival in patients with traumatic-induced coagulopathy. J Trauma: 2009; 67 33 37
92. Burdess A, Nimmo AF, Garden OJ et al. Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg: 2010; 252 37 42
93. Metzler H, Kozek-Langenecker S, Huber K. Antiplatelet therapy and coronary stents in perioperative medicine the two sides of the coin. Best Pract Res Clin Anaesthesiol: 2008; 22 81 94 (Pubitemid 351418963)
94. Fleisher LA et al. WRITING COMMITTEE 2009 ACCF/AHA focused update on peri-operative beta blockade incorporated into the ACC/AHA 2007 guidelines on peri-operative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation: 2009; 120
95. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation review and meta-analysis. J Intern Med: 2005; 257 399 414 (Pubitemid 40604544)
96. Metzler H, Huber K, Kozek-Langenecker S et al. Coronary stents, dual antiplatelet therapy and perioperative problems. Anaesthesist: 2007; 56 401 410
97. Korte W, Cattaneo M, Chassot PG et al. Perioperative management of antiplatelet therapy in patients with coronary artery disease. Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost: 2011; 105 743 749
98. Savonitto S, D'Urbano M, Caracciolo M et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of bridging antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth: 2010; 104 285 291
99. Choi WS, Irwin MG, Samman N. The effect of tranexamic acid on blood loss during orthognathic surgery: a randomized controlled trial. J Oral Maxillofac Surg: 2009; 67 125 133
100. Ralley FE, Berta D, Binns V et al. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res: 2010; 468 1905 1911
101. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ: 2009; 180 183 193
102. Murkin JM, Falter F, Granton J et al. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesthesia & Analgesia: 2010; 110 350 353
103. Habler O, Meier J, Pape A et al. Perioperative Anmietoleranz. Anaesthesist: 2006; 55 1142 1156
104. Meier J, Kemming G, Meisner F et al. Hyperoxic ventilation enables hemodilution beyond the critical myocardial hemoglobin concentration. Eur J Med Res: 2005
105. Gombotz H, Rigler B, Matzer C et al. 10 years' experience with heart surgery in Jehovah's witnesses. Anaesthesist: 1989; 38 385 390 (Pubitemid 19203316)
106. Habler O, Voss B. Perioperative management of Jehovah's Witness patients. Special consideration of religiously motivated refusal of allogeneic blood transfusion. Anaesthesist: 2010; 59 297 311
107. Hogue CW Jr. , Goodnough LT, Monk TG. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion: 1998; 38 924 931 (Pubitemid 28467220)
108. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med: 1993; 21 860 866 (Pubitemid 23173023)
109. Aronson D, Dann EJ, Bonstein L et al. Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol: 2008; 102 115 119
110. Mantilla CB, Wass CT, Goodrich KA et al. Risk for perioperative myocardial infarction and mortality in patients undergoing hip or knee arthroplasty: the role of anemia. Transfusion: 2011; 51 82 91
111. Spahn DR, Zollinger A, Schlumpf RB et al. Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg: 1996; 82 681 686 (Pubitemid 26111561)
112. Grover M, Talwalkar S, Casbard A et al. Silent myocardial ischaemia and haemo-globin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang: 2006; 90 105 112 (Pubitemid 43381498)
113. Spahn DR, Seifert B, Pasch T, Schmid ER. Effects of chronic beta-blockade on compensatory mechanisms during acute isovolaemic haemodilution in patients with coronary artery disease. Br J Anaesth: 1997; 78 381 385 (Pubitemid 27179888)
114. Spahn DR, Schmid ER, Seifert B, Pasch T. Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg: 1996; 82 687 694 (Pubitemid 26111562)
115. Spahn DR, Seifert B, Pasch T, Schmid ER. Haemodilution tolerance in patients with mitral regurgitation. Anaesthesia: 1998; 53 20 24 (Pubitemid 28033684)
116. Beattie WS, Wijeysundera DN, Karkouti K et al. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology: 2010; 112 25 33
117. Cromheecke S, Lorsomradee S, Van der Linden PJ, De Hert SG. Moderate acute isovolemic hemodilution alters myocardial function in patients with coronary artery disease. Anesth Analg: 2008; 107 1145 1152
118. Beguin C, Closon MC, Vandekerckhove P, Baele P. Concentration of transfusion resources on a few pathologies and a few patients: analysis of the comprehensive in-hospital patient database. Transfusion: 2007; 47 217 227 (Pubitemid 46146555)
119. Cabrales P, Intaglietta M, Tsai AG. Transfusion restores blood viscosity and reinstates microvascular conditions from hemorrhagic shock independent of oxygen carrying capacity. Resuscitation: 2007; 75 124 134 (Pubitemid 47331993)
120. Dani C, Pratesi S, Fontanelli G et al. Blood transfusions increase cerebral, splanchnic, and renal oxygenation in anemic preterm infants. Transfusion: 2010
121. Grant MJ, Huether SE, Witte MK. Effect of red blood cell transfusion on oxygen consumption in the anemic pediatric patient. Pediatr Crit Care Med: 2003; 4 459 464
122. Vuille-Lessard E, Boudreault D, Girard F et al. Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study. Transfusion: 2010; 50 2117 2124
123. Carson JL, Terrin ML, Barton FB et al. A pilot randomized trial comparing symp-tomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion: 1998; 38 522 529 (Pubitemid 28317227)
124. Orlov D, O'Farrell R, McCluskey SA et al. The clinical utility of an index of global oxygenation for guiding red blood cell transfusion in cardiac surgery. Transfusion: 2009; 49 682 688
125. Rosencher N, Kerkkamp HE, Macheras G et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion: 2003; 43 459 469 (Pubitemid 36428328)
126. Snyder-Ramos SA et al. investigators of the Multicenter Study of Perioperative Ischemia MRG The ongoing variability in blood transfusion practices in cardiac surgery. Transfusion: 2008; 48 1284 1299
127. Hill SR, Carless PA, Henry DA et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev CD 002042: 2002
128. American Society of Anesthesiologists Task Force on Perioperative Blood Trans-fusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology: 2006; 105 198 208
129. Ferraris VA, Ferraris SP, Saha SP et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg: 2007; 83 05
130. Napolitano LM, Kurek S, Luchette FA et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med: 2009; 37 3124 3157
131. Anker SD, Voors A, Okonko D et al. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J: 2009; 30 1331 1339
132. McGill JB, Bell DS. Anemia and the role of erythropoietin in diabetes. J Diabetes Complications: 2006; 20 262 272 (Pubitemid 44202266)
133. Wexler D, Silverberg D, Sheps D et al. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. Int J Cardiol: 2004; 96 79 87 (Pubitemid 38760242)
134. Weiss G, Goodnough LT. Anemia of chronic disease. New England Journal of Medicine: 2009; 352 1011 1023
135. Shander A. Surgery without blood. Crit Care Med: 2003; 31 12
136. Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J: 2009; 30 2769 2812